Wenxin Zheng
Researcher
Also affiliated: Northwestern University (2021); University of Jordan (2013); University of Southern California (1997–2002); Gynecologic Oncology Group (1995); Parkland Memorial Hospital (2020–2024); Parkland Health & Hospital System (2022–2023); Roswell Park Comprehensive Cancer Center (2019); National Institutes of Health (2006–2024); Bloomberg (United States) (2015); Beth Israel Deaconess Medical Center (2017); Cleveland Clinic (2019); Yale New Haven Hospital (2005); State University of New York (2006–2007); Mayo Clinic (2006); Memorial Sloan Kettering Cancer Center (2019); Children's Hospital of Los Angeles (1999); Shanghai Medical College of Fudan University (2006–2008); University of Wisconsin–Madison (2004); Harvard University (2011–2017); University of Arizona (2006–2019); University of Kentucky (2006); Johns Hopkins University (2013–2015); Shandong University (2009–2017); Harbin Medical University (2011–2017); Gleason (United States) (2018); University of California, Los Angeles (2000); The University of Texas at Dallas (2021); Xinjiang Agricultural University (2025); Henan University (2018–2019); Shanxi Medical University (2014); Second Military Medical University (2010); Capital Medical University (2012); Providence College (1997); Chinese Academy of Sciences (2009); Vanderbilt University (2013–2017); Cornell University (1995); Fudan University (2006–2008); University Hospitals of Cleveland (2007); Queen Mary Hospital (2019); Women's and Children's Hospital (2019); Yale University (2001–2017); University of California San Diego (2017–2018); Northwest University (2023); In-Q-Tel (2010); Zhengzhou University (2019); University of Chicago (2016); Daqing City People's Hospital (2017); Massachusetts General Hospital (2011); National Institute of Pathology (2002); Southwestern Medical Center (2015–2025); Daqing Oilfield General Hospital (2017); Shanghai Institutes for Biological Sciences (2005–2009); Beijing Enterprises (China) (2025); National Institute of Neurological Disorders and Stroke (2006); Huntington Hospital (2006); Bipar (2013); Winthrop Rockefeller Foundation (2025); Institute of Immunology (2005); Women & Infants Hospital of Rhode Island (1997); Henan Provincial People's Hospital (2018–2019); Xinjiang Academy of Animal Science (2024); Shanghai First People's Hospital (2024); Harvard Vanguard Medical Associates (2017); Shanghai Pudong New Area Gongli Hospital (2010); Shandong Provincial QianFoShan Hospital (2018); Qilu Hospital of Shandong University (2010–2014); Arizona Oncology (2009–2017); Beijing Obstetrics and Gynecology Hospital (2020–2025); Southwestern Medical Center (2019–2025); University of Arizona Cancer Center (2014); Harold C. Simmons Comprehensive Cancer Center (2018–2023); University of Colorado Anschutz Medical Campus (2019); The Ohio State University (2019); Indiana University – Purdue University Indianapolis (2007); Stony Brook University (2006–2007); Southwest Minzu University (2023–2025); University of Maryland, College Park (2006); Zhejiang University (2020); Columbia University (1989–1990); Saitama Medical University (2019); The University of Texas Southwestern Medical Center (2015–2025); University of Hong Kong (2019); China Medical University (2025)
Faculty Researcher
Upstream record may be merged OpenAlex, the source of these figures, lists 84 institutions in 9 countries for this author record — a pattern that usually means it combines several researchers with similar names. The totals above may include work by other people.
Biomedical Subjects
Links
Biography and Research Information
Metrics
- h-index: 49
- Publications: 297
- Citations: 7,163
Selected Publications
-
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer: final analysis of the randomized RATIONALE-315 trial (2025)
-
Cytopathologic features of mesonephric-like adenocarcinoma in the endometrium and ovary: eight cases and literature review (2025)
-
Effects of MSTN Gene Knockout on Growth Performance and Muscle Transcriptome in Chinese Merino Sheep (Xinjiang Type) (2025)
-
High-grade endometrioid carcinomas with pilomatrix-like features lacking CTNNB1 Mutations: Clinicopathologic characteristics and novel molecular events (2025)
-
[Research progress in treatment of ulcerative colitis with traditional Chinese medicine]. (2025)
-
Pilomatrix-like High-grade Endometrial Carcinoma (2025)
-
GNA15 predicts poor outcomes as a novel biomarker related to M2 macrophage infiltration in ovarian cancer (2025)
-
Endometrial polyps with bizarre stromal cells: a Benign or a low-grade lesion? (2025)
-
Effect of differences in residual feed intake on gastrointestinal microbiota of Dexin fine-wool meat sheep (2024)
-
Dysregulation of DNA methylation in colorectal cancer: biomarker, immune regulation, and therapeutic potential (2024)
-
FIGO 2023 staging for endometrial cancer, when, if it is not now? (2024)
-
Diagnostic and prognostic potential of the intra-tumoral microbiota profile in HPV-independent endocervical adenocarcinoma (2024)
-
β-catenin, PAX2, and PTEN Aberrancy Across the Spectrum of Endometrioid Ovarian Lesions (2024)
-
Expression and Prognostic Significance of LAG-3, TIGIT, VISTA, and IDO1 in Endometrial Serous Carcinoma (2024)
-
Phosphorylation of IDH1 Facilitates Progestin Resistance in Endometrial Cancer (2024)
Collaboration Network
Top Collaborators
- Morules But Not Squamous Differentiation are a Reliable Indicator of CTNNB1 (β-catenin) Mutations in Endometrial Carcinoma and Precancers
- Utility of a PAX2, PTEN, and β-catenin Panel in the Diagnosis of Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia in Endometrial Polyps
- Serial genomic analysis of endometrium supports the existence of histologically indistinct endometrial cancer precursors
- Endometrial polyps are non-neoplastic but harbor epithelial mutations in endometrial cancer drivers at low allelic frequencies
- Prevalence and prognostic significance of PD-L1, TIM-3 and B7-H3 expression in endometrial serous carcinoma
Showing 5 of 13 shared publications
- Morules But Not Squamous Differentiation are a Reliable Indicator of CTNNB1 (β-catenin) Mutations in Endometrial Carcinoma and Precancers
- Utility of a PAX2, PTEN, and β-catenin Panel in the Diagnosis of Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia in Endometrial Polyps
- Serial genomic analysis of endometrium supports the existence of histologically indistinct endometrial cancer precursors
- Endometrial polyps are non-neoplastic but harbor epithelial mutations in endometrial cancer drivers at low allelic frequencies
- Prevalence and prognostic significance of PD-L1, TIM-3 and B7-H3 expression in endometrial serous carcinoma
Showing 5 of 11 shared publications
- Dissection of transcriptome dysregulation and immune characterization in women with germline BRCA1 mutation at single-cell resolution
- Pilomatrix-like High-grade Endometrial Carcinoma
- HPV Genotype Specific and Age Stratified Immediate Prevalence of Cervical Precancers and Cancers in Women with NILM/hrHPV+: A Single Center Retrospective Study of 26,228 Cases
- Diagnostic and prognostic potential of the intra-tumoral microbiota profile in HPV-independent endocervical adenocarcinoma
- Prevalence of cervical precancers or cancers in women with ASC-H/HSIL cytology according to Aptima HPV (AHPV) assay-detected HPV genotypes and age
Showing 5 of 10 shared publications
- Dissection of transcriptome dysregulation and immune characterization in women with germline BRCA1 mutation at single-cell resolution
- GNA15 predicts poor outcomes as a novel biomarker related to M2 macrophage infiltration in ovarian cancer
- Pilomatrix-like High-grade Endometrial Carcinoma
- Diagnostic and prognostic potential of the intra-tumoral microbiota profile in HPV-independent endocervical adenocarcinoma
- Predicting Progestin Therapy Response With PTEN, PAX2, and β-Catenin in Patients With Endometrioid Precancer
Showing 5 of 10 shared publications
- Morules But Not Squamous Differentiation are a Reliable Indicator of CTNNB1 (β-catenin) Mutations in Endometrial Carcinoma and Precancers
- Utility of a PAX2, PTEN, and β-catenin Panel in the Diagnosis of Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia in Endometrial Polyps
- Serial genomic analysis of endometrium supports the existence of histologically indistinct endometrial cancer precursors
- Endometrial polyps are non-neoplastic but harbor epithelial mutations in endometrial cancer drivers at low allelic frequencies
- Prevalence and prognostic significance of PD-L1, TIM-3 and B7-H3 expression in endometrial serous carcinoma
Showing 5 of 9 shared publications
- Morules But Not Squamous Differentiation are a Reliable Indicator of CTNNB1 (β-catenin) Mutations in Endometrial Carcinoma and Precancers
- Endometrial stromal tumors: Diagnostic updates and challenges
- Utility of a PAX2, PTEN, and β-catenin Panel in the Diagnosis of Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia in Endometrial Polyps
- Prevalence and prognostic significance of PD-L1, TIM-3 and B7-H3 expression in endometrial serous carcinoma
- Navigating through perplex morphologic changes after exogenous hormone usage
Showing 5 of 9 shared publications
- Morules But Not Squamous Differentiation are a Reliable Indicator of CTNNB1 (β-catenin) Mutations in Endometrial Carcinoma and Precancers
- Utility of a PAX2, PTEN, and β-catenin Panel in the Diagnosis of Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia in Endometrial Polyps
- Prevalence and prognostic significance of PD-L1, TIM-3 and B7-H3 expression in endometrial serous carcinoma
- Navigating through perplex morphologic changes after exogenous hormone usage
- Tumor Necrotic Debris and High Nuclear Grade
Showing 5 of 8 shared publications
- Morules But Not Squamous Differentiation are a Reliable Indicator of CTNNB1 (β-catenin) Mutations in Endometrial Carcinoma and Precancers
- Utility of a PAX2, PTEN, and β-catenin Panel in the Diagnosis of Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia in Endometrial Polyps
- Prevalence and prognostic significance of PD-L1, TIM-3 and B7-H3 expression in endometrial serous carcinoma
- Navigating through perplex morphologic changes after exogenous hormone usage
- Expression and Prognostic Significance of LAG-3, TIGIT, VISTA, and IDO1 in Endometrial Serous Carcinoma
Showing 5 of 7 shared publications
- Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma
- The IVF-generated human embryonic microenvironment reverses progestin resistance in endometrial cancer cells by inducing cancer stem cell differentiation
- Brusatol sensitizes endometrial hyperplasia and cancer to progestin by suppressing NRF2-TET1-AKR1C1-mediated progestin metabolism
- LASS2 mediates Nrf2-driven progestin resistance in endometrial cancer.
- Phosphorylation of IDH1 Facilitates Progestin Resistance in Endometrial Cancer
Showing 5 of 6 shared publications
- Utility of a PAX2, PTEN, and β-catenin Panel in the Diagnosis of Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia in Endometrial Polyps
- Serial genomic analysis of endometrium supports the existence of histologically indistinct endometrial cancer precursors
- Endometrial polyps are non-neoplastic but harbor epithelial mutations in endometrial cancer drivers at low allelic frequencies
- β-catenin, Pax2, and Pten Panel Identifies Precancers Among Histologically Subdiagnostic Endometrial Lesions
- β-catenin, PAX2, and PTEN Aberrancy Across the Spectrum of Endometrioid Ovarian Lesions
- Serial genomic analysis of endometrium supports the existence of histologically indistinct endometrial cancer precursors
- Endometrial polyps are non-neoplastic but harbor epithelial mutations in endometrial cancer drivers at low allelic frequencies
- β-catenin, Pax2, and Pten Panel Identifies Precancers Among Histologically Subdiagnostic Endometrial Lesions
- β-Catenin, PAX2 and PTEN panel in the diagnosis of endometrial precancers: a case-based review
- β-catenin, PAX2, and PTEN Aberrancy Across the Spectrum of Endometrioid Ovarian Lesions
- Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma
- Brusatol sensitizes endometrial hyperplasia and cancer to progestin by suppressing NRF2-TET1-AKR1C1-mediated progestin metabolism
- LASS2 mediates Nrf2-driven progestin resistance in endometrial cancer.
- Assisted reproductive technology treatment failure and the detection of intrauterine HPV through spent embryo transfer media sample
- TSLP enhances progestin response in endometrial cancer via androgen receptor signal pathway
- The IVF-generated human embryonic microenvironment reverses progestin resistance in endometrial cancer cells by inducing cancer stem cell differentiation
- Brusatol sensitizes endometrial hyperplasia and cancer to progestin by suppressing NRF2-TET1-AKR1C1-mediated progestin metabolism
- Phosphorylation of IDH1 Facilitates Progestin Resistance in Endometrial Cancer
- TSLP enhances progestin response in endometrial cancer via androgen receptor signal pathway
- Brusatol Sensitizes Endometrial Hyperplasia and Cancer to Progestin by Suppressing Nrf2-Tet1-AKR1C1-Mediated Progestin Metabolism
- HPV Genotype Specific and Age Stratified Immediate Prevalence of Cervical Precancers and Cancers in Women with NILM/hrHPV+: A Single Center Retrospective Study of 26,228 Cases
- Diagnostic and prognostic potential of the intra-tumoral microbiota profile in HPV-independent endocervical adenocarcinoma
- Correlation of immediate prevalence of cervical precancers and cancers with HPV genotype and age in women with ASC-US/hrHPV+: a retrospective analysis of 2292 cases
- Correlation of immediate prevalence of cervical precancers and cancers with HPV genotype and age in women with atypical glandular cells cytology: A retrospective analysis of 369 cases
- Cytopathologic features of mesonephric-like adenocarcinoma in the endometrium and ovary: eight cases and literature review
- Morules But Not Squamous Differentiation are a Reliable Indicator of CTNNB1 (β-catenin) Mutations in Endometrial Carcinoma and Precancers
- Utility of a PAX2, PTEN, and β-catenin Panel in the Diagnosis of Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia in Endometrial Polyps
- Prevalence and prognostic significance of PD-L1, TIM-3 and B7-H3 expression in endometrial serous carcinoma
- Navigating through perplex morphologic changes after exogenous hormone usage
- Expression and Prognostic Significance of LAG-3, TIGIT, VISTA, and IDO1 in Endometrial Serous Carcinoma